What THC Farmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Howells Thomas J | Director | Nov 18 | Open-market sale · S | −1,248,750 | $0.03 | −$41.7K | 175,000 |
| Jenson Travis T | Insider | Nov 18 | Open-market sale · S | −1,322,750 | $0.03 | −$41.7K | 96,000 |
| Jones Calvin K | Insider | Nov 18 | Open-market sale · S | −1,440,625 | $0.03 | −$49K | 200,000 |
| Aguirre Jennifer A | Insider | Nov 18 | Open-market sale · S | −1,000,000 | $0.03 | −$34K | 0 |
| Trimble Kelly | Director | Nov 18 | Open-market sale · S | −2,496,875 | $0.33 | −$834K | 275,000 |
| Trimble Kelly | Director | Nov 17 | Open-market sale · S | −2,496,875 | $0.03 | −$83.4K | 275,000 |
Loading...
